Atherosclerosis is considered one of the primary causes of cardiovascular diseases (CVDs).
Unpredictable rupture of the vulnerable atherosclerotic plaques triggers adverse …

Cardiovascular diseases have become the major killers in today's world, among which
coronary artery diseases (CADs) make the greatest contributions to morbidity and mortality …

Macrophage immunotherapy represents an emerging therapeutic approach aimed at
modulating the immune response to alleviate disease symptoms. Nanomaterials (NMs) have …

Atherosclerosis is a chronic inflammatory disease involved in plaque rupture, stroke,
thrombosis, and heart attack (myocardial infarction), which is a leading cause of sudden …

Coronary heart disease (CHD) is one of the major causes of death and disability worldwide,
especially in low-and middle-income countries and among older populations. Conventional …

Cardiovascular diseases refer to a group of the circulatory system disorders, including
atherosclerosis, thrombosis, myocardial/cerebral infarction and the following ischemia …

Imaging and tracking macrophage behaviors in vivo are essential to reveal its biological
function and fate in various diseases. Small molecular probes suffer from poor macrophage …

Targeting nanoparticle is a very promising therapeutic approach that can precisely target
specific sites to treat diseases. Research on nanoscale drug delivery systems has made …

Unlike stable atherosclerotic plaques, vulnerable plaques are very likely to cause serious
cardio-cerebrovascular diseases. Meanwhile, how to non-invasively identify vulnerable …

The improved drug delivery systems (DDS) are needed for the targeted delivery of their
therapeutic cargo (biologically active protein/peptide molecules, nucleic acids, vaccines …